Edition:
United Kingdom

Apollo Endosurgery Inc (APEN.OQ)

APEN.OQ on NASDAQ Stock Exchange Global Market

6.89USD
21 Sep 2018
Change (% chg)

$-0.26 (-3.64%)
Prev Close
$7.15
Open
$7.12
Day's High
$7.12
Day's Low
$6.89
Volume
8,271
Avg. Vol
15,162
52-wk High
$9.56
52-wk Low
$3.77

Latest Key Developments (Source: Significant Developments)

Apollo Endosurgery Inc - QTRLY Net Loss Per Share, Basic And Diluted $0.53
Wednesday, 8 Aug 2018 

Apollo Endosurgery Inc ::APOLLO ENDOSURGERY, INC. REPORTS SECOND QUARTER 2018 RESULTS.Q2 REVENUE $15.8 MILLION VERSUS I/B/E/S VIEW $16.6 MILLION.CASH, CASH EQUIVALENTS AND RESTRICTED CASH WERE $35.4 MILLION AS OF JUNE 30, 2018.QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.53.Q2 EARNINGS PER SHARE VIEW $-0.44 -- THOMSON REUTERS I/B/E/S.  Full Article

Apollo Endosurgery Announces Pricing Of $20.6 Million Public Offering Of Common Stock
Wednesday, 20 Jun 2018 

June 20 (Reuters) - Apollo Endosurgery Inc ::APOLLO ENDOSURGERY, INC. ANNOUNCES PRICING OF $20.6 MILLION PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 3.75 MILLION COMMON SHARES PRICED AT $5.50PER SHARE.  Full Article

Apollo Endosurgery Announces Approval Orbera365 In Saudi Arabia
Monday, 23 Apr 2018 

April 23 (Reuters) - Apollo Endosurgery Inc ::APOLLO ENDOSURGERY ANNOUNCES APPROVAL OF THE NEW 12-MONTH WEIGHT LOSS BALLOON - ORBERA365™ - IN THE KINGDOM OF SAUDI ARABIA.APOLLO ENDOSURGERY INC - SAUDI FOOD AND DRUG AUTHORITY APPROVED ORBERA365 MANAGED WEIGHT LOSS SYSTEM & ISSUED MEDICAL DEVICE MARKETING AUTHORIZATION.APOLLO ENDOSURGERY INC - MDMA ALLOWS CO TO MARKET ORBERA365 IN KINGDOM OF SAUDI ARABIA WITH ITS EXCLUSIVE DISTRIBUTION PARTNER, AL-NOZHA MEDICAL.  Full Article

Apollo Endosurgery Inc Files For Stock Shelf Of Upto $50 Million - SEC Filing ‍​
Monday, 4 Dec 2017 

Dec 4 (Reuters) - Apollo Endosurgery Inc ::APOLLO ENDOSURGERY INC FILES FOR STOCK SHELF OF UPTO $50 MILLION - SEC FILING ‍​.  Full Article

Apollo Endosurgery Receives FDA Clearance For Overstitch Sx Endoscopic Suturing System
Monday, 27 Nov 2017 

Nov 27 (Reuters) - Apollo Endosurgery Inc ::APOLLO ENDOSURGERY RECEIVES FDA CLEARANCE FOR OVERSTITCH™ SX ENDOSCOPIC SUTURING SYSTEM.APOLLO ENDOSURGERY INC - ‍U.S. FOOD AND DRUG ADMINISTRATION 510K CLEARANCE OF OVERSTITCH SX​.APOLLO ENDOSURGERY INC - ‍PLANS TO INTRODUCE SX SYSTEM IN US AND EUROPE IN FIRST HALF OF 2018​.  Full Article

Apollo Endosurgery reports qtrly loss per share $‍0.32​
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Apollo Endosurgery Inc :Apollo Endosurgery Inc reports third quarter 2017 results.Q3 sales $16.5 million versus I/B/E/S view $16.7 million.Apollo Endosurgery Inc - qtrly loss per share $‍0.32​.  Full Article

UPDATE 1-FDA reports 5 more deaths related to intragastric balloons

June 4 The U.S. Food and Drug Administration on Monday notified healthcare providers that it had received reports of five more deaths in patients using liquid-filled intragastric balloon systems to treat obesity, bringing the total death toll to 12 since 2016.